PRKCQ and colorectal cancer: Previously, studies have identified dysregulation of lncRNA-protein kinase C theta antisense RNA 1 (PRKCQ-AS1) to be associated with cancer progression, including colorectal cancer, triple-negative breast cancer [15–17].